Last reviewed · How we verify
Noltec (ILAPRAZOLE)
At a glance
| Generic name | ILAPRAZOLE |
|---|---|
| Drug class | Proton Pump Inhibitors |
| Target | Potassium-transporting ATPase |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Approved indications
- Gastroesophageal reflux disease
- Peptic ulcer
Common side effects
Drug interactions
- clopidogrel
- dasatinib
- delavirdine
- erlotinib
- nelfinavir
- ponatinib
- rilpivirine
- risedronic acid
Key clinical trials
- Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer (PHASE3)
- Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SR (PHASE1)
- Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T (PHASE1)
- Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding (PHASE4)
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac (PHASE1)
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole (PHASE1)
- A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding (PHASE3)
- Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Noltec CI brief — competitive landscape report
- Noltec updates RSS · CI watch RSS